Blog
RSS FeedPosted by Michael Wonder on 31 Aug 2025
FDA approval of Leqembi subcutaneous formulation charts path to combination therapies for Alzheimer's disease
29 August 2025 - Subcutaneous delivery increases accessibility and introduces potential for at home administration, following model of diabetes and ...
Posted by Michael Wonder on 09 Aug 2022
CorMedix announces regulatory and manufacturing updates
8 August 2022 - CorMedix today announced a second complete response letter was received from the FDA stating that the DefenCath ...
Posted by Michael Wonder on 09 Aug 2022
Reata Pharmaceuticals announces three month extension of the review period for new drug application for omaveloxolone for the treatment of Friedreich’s ataxia
9 August 2022 - PDUFA date extended to 28 February 2023. ...
Posted by Michael Wonder on 08 Aug 2022
Monkeypox vaccines: here’s how many have been shipped and where as White House declares public health emergency
8 August 2022 - The US Government has shipped more than 602,000 doses of Jynneos monkeypox vaccines—the only shot specifically approved ...
Posted by Michael Wonder on 08 Aug 2022
Monkeypox vaccines have arrived in Victoria. Here's how the rollout will work.
9 August 2022 - As concern about how to curb monkeypox continues at a global level, the first few thousand ...
Posted by Michael Wonder on 08 Aug 2022
The GOP blocked an insulin price cap: What it means for diabetics
8 August 2022 - The Senate passed a sweeping budget package Sunday intended to bring financial relief to Americans, but ...
Posted by Michael Wonder on 08 Aug 2022
Bot Image receives FDA clearance for artificial intelligence software used in detection and diagnosis of prostate cancer
8 August 2022 - Bot Image has developed an AI driven medical device CAD software to significantly improve the accuracy and ...
Posted by Michael Wonder on 08 Aug 2022
Pear Therapeutics and SelectHealth announce coverage to provide access to FDA authorised prescription digital therapeutic for the treatment of opioid use disorder
8 August 2022 - SelectHealth teams with Pear to provide its members with covered access to Pear’s innovative prescription digital therapeutic, ...
Posted by Michael Wonder on 08 Aug 2022
PhRMA’s Ubl calls Senate passage of partisan drug pricing plan a “tragic loss for patients”
7 August 2022 - PhRMA President and CEO Stephen J. Ubl released the following statement after the U.S. Senate passed ...
Posted by Michael Wonder on 08 Aug 2022
Lurbinectedin receives the Innovative Medicine designation by the UK’s MHRA
5 August 2022 - PharmaMar has announced today that Zepzelca (lurbinectedin) has received the Innovation Passport (Innovative Medicine designation) by the ...
Posted by Michael Wonder on 08 Aug 2022
Democrats vote to raise drug prices
7 August 2022 - Price controls for Medicare mean higher costs for everyone else. ...
Posted by Michael Wonder on 08 Aug 2022
SMC - August 2022 decisions
8 August 2022 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
Posted by Michael Wonder on 08 Aug 2022
Lilly's Taltz (ixekizumab) now available in new, citrate free formulation to reduce injection site pain for improved patient experience
8 August 2022 - Since the medicine's first approval in 2016, nearly 130,000 people in the U.S. have been treated ...
Posted by Michael Wonder on 08 Aug 2022
Mayne Pharma and Mithra announce FDA approval of Haloette, a generic version of Nuvaring
8 August 2022 - Mayne Pharma and Mithra Pharmaceuticals are pleased to announce that the U.S. FDA has granted approval ...
Posted by Michael Wonder on 08 Aug 2022
Funding for lifesaving drug denied by B.C. health authority as couple struggles to fund their portion
7 August 2022 - Entrectinib, a targeted drug that had shown positive results in tumours that had the same gene expression, ...
Posted by Michael Wonder on 07 Aug 2022
Democrats will have to limit their drug pricing reforms to Medicare to comply with Senate rules
6 August 2022 - Democrats will likely have to axe two provisions from their drug pricing plan to fit in ...